How was treatment response assessed on the PROSPECT trial?
Specifically, on re-staging imaging, would the tumor regression be strictly defined by reduction in cranio-caudal direction only, or would other measurements need to be taken into consideration?
Schrag et al., PMID 37272534
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · Brigham and Women's Hospital
Answered on
Dr. Harvey reached out to his colleague, Dr. Marc Gollub, director of radiology at Memorial Sloan Kettering with expertise in gastrointestinal imaging (and who was the radiologist who collaborated on PROSPECT), for his thoughts on this question. Here is his answer:
- I had to “create” a non-volum...
Join for free or sign in to see the full answer